---
title: "Aprea Therapeutics (APRE.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/APRE.US/norm.md"
symbol: "APRE.US"
name: "Aprea Therapeutics"
parent: "https://longbridge.com/en/quote/APRE.US.md"
datetime: "2026-05-19T20:20:56.421Z"
locales:
  - [en](https://longbridge.com/en/quote/APRE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/APRE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/APRE.US/norm.md)
---

# Aprea Therapeutics (APRE.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2239 | -0.3194 | -0.4664 | -0.5324 | -0.6561 |
| ROE | -48.68% | -84.12% | -97.75% | -89.46% | -90.26% |
| Revenue | - | 3337.00 | 1848.00 | 118111.00 | 162463.00 |
| Net income | -3.29M | -2.46M | -2.97M | -3.24M | -3.93M |
| Operating income | -3.43M | -2.64M | -3.12M | -3.39M | -4.09M |
| Gross margin | - | -30131.91% | -88585.98% | -1519.00% | -1428.39% |
| Net margin | - | -73587.95% | -160844.70% | -2742.23% | -2420.65% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 47.61M | 15.93M | 14.32M | 17.31M | 20.22M |
| Leverage | 1.13 | 1.21 | 1.23 | 1.22 | 1.20 |
| BVPS | 3.47 | 1.52 | 1.83 | 2.33 | 2.82 |
| Turnover | 0.0036 | 0.0143 | 0.0237 | 0.0356 | 0.0481 |
| Cash & STI | 46.47M | 14.60M | 13.72M | 16.53M | 19.28M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 54379.00 | 59807.00 | 65236.00 | 70665.00 | 76093.00 |
| Net debt | -46.47M | -14.60M | -13.72M | -16.53M | -19.28M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.76M | -2.96M | -3.17M | -3.13M | -3.63M |
| Investing CF | - | - | - | - | - |
| Financing CF | 34.62M | 3.84M | 357940.00 | 384879.00 | 55849.00 |
| Free CF | 576369.00 | -2.15M | -2.16M | -2.04M | -2.26M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |